Kunshengtai Medicine - B (02511.HK) announced its interim performance as of the end of June this year. Other income and gains amounted to 38.273 million yuan (the same below), an increase of 68.4% year-on-year. The loss narrowed to 0.211 billion yuan, compared to a loss of 0.55 billion yuan in the same period last year; loss per share was 0.47 yuan. No dividend will be distributed.